Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)

CUSIP: 86366E106

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class
Equity / Ordinary Shares, par value $0.0001 per share
Total 13F shares
60,660,143
Total 13F value
$1,645,431,741
Holder snapshot 6 visible 7 signals
Share change
-2,353,424
Put/Call ratio
53%
SEC-reported price per share
$27.12
Number of holders
162
Value change
-$123,990,833
Number of buys
83
Open additional details 1 more signal available
Number of sells
72
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
213,001,347

Security key

86366E106

Report period

Q4 2024

Institutions

162

Top holders

10

GPCR full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Structure Therapeutics Inc. SEC filings Structure Therapeutics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F 3/4/5 Lead comparable stake: 3.6% Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 3.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership Top 5
WELLINGTON MANAGEMENT GROUP LLP 3.6%
FMR LLC 2.9%
Janus Henderson Group Ltd. 1.9%
Capital Research Global Investors 1.7%
DRIEHAUS CAPITAL MANAGEMENT LLC 1.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
3.6%
$341,015,248
7,769,771 shares
 — 30 Sep 2024
FMR LLC
13F
Company
13F
2.9%
$268,977,407
6,128,444 shares
 — 30 Sep 2024
Janus Henderson Group Ltd.
13F
Company
13F
1.9%
$173,623,444
3,956,878 shares
 — 30 Sep 2024
Capital Research Global Investors
13F
Company
13F
1.7%
$154,951,451
3,530,450 shares
 — 30 Sep 2024
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
13F
1.2%
$110,885,013
2,526,430 shares
 — 30 Sep 2024
FEDERATED HERMES, INC.
13F
Company
13F
1.1%
$105,845,124
2,411,600 shares
 — 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
162
Shares
60,660,143
Rows available
162
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
160
Q4 2024 holders
162
Holder diff
2
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .